InMode (INMD) Cash & Current Investments (2018 - 2026)
InMode (INMD) posted Cash & Current Investments of $480.1 million for Q1 2026, up 1.79% sequentially from $471.7 million in Q4 2025, and up 66.44% YoY from $288.5 million in Q1 2025.
InMode (INMD) Cash & Current Investments (2018 - 2026) Analysis & Trends
InMode has reported Cash & Current Investments for 9 years, with the latest figure at $480.1 million in Q1 2026.
- Quarterly Cash & Current Investments rose 66.44% year-over-year to $480.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $480.1 million (up 66.44% YoY) and the FY2025 annual result came in at $471.7 million, up 43.47% from the prior year.
- Cash & Current Investments advanced to $480.1 million in Q1 2026 per INMD's latest filing, from $471.7 million in the prior quarter.
- Over five years, Cash & Current Investments peaked at $480.1 million in Q1 2026 and troughed at $101.1 million in Q1 2022.
- A 5-year average of $300.7 million and a median of $327.3 million in 2025 frame the typical range for Cash & Current Investments.
- The sharpest annual moves came in 2024 and 2025: Cash & Current Investments jumped 125.01% in 2024, then decreased 24.04% in 2025.
- Over 5 years, Cash & Current Investments stood at $172.8 million in 2022, then jumped by 112.95% to $368.0 million in 2023, then decreased by 10.65% to $328.8 million in 2024, then surged by 43.47% to $471.7 million in 2025, then advanced by 1.79% to $480.1 million in 2026.
- According to Business Quant data, Cash & Current Investments over the past three periods registered $480.1 million, $471.7 million, and $410.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | 5.60 Bn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 3.48 Bn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 9.22 Bn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 539.00 Mn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 4.25 Bn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 1.95 Bn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 2.11 Bn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 3.32 Bn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 482.30 Mn |
| 10 | InMode | 921.69 Mn | 506.52 Mn | 71.52 Mn | 415.17 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 480.13 Mn |
| Dec 31, 2025 | 471.70 Mn |
| Sep 30, 2025 | 410.79 Mn |
| Jun 30, 2025 | 327.30 Mn |
| Mar 31, 2025 | 288.47 Mn |
| Dec 31, 2024 | 328.78 Mn |
| Sep 30, 2024 | 403.43 Mn |
| Jun 30, 2024 | 395.69 Mn |
| Mar 31, 2024 | 379.76 Mn |
| Dec 31, 2023 | 367.96 Mn |
| Sep 30, 2023 | 289.99 Mn |
| Jun 30, 2023 | 228.95 Mn |
| Mar 31, 2023 | 168.78 Mn |
| Dec 31, 2022 | 172.79 Mn |
| Sep 30, 2022 | 151.45 Mn |
| Jun 30, 2022 | 144.32 Mn |
| Mar 31, 2022 | 101.06 Mn |
| Dec 31, 2021 | 121.38 Mn |
| Sep 30, 2021 | 122.15 Mn |
| Jun 30, 2021 | 114.03 Mn |